Edesa Biotech Profit Margin 2013-2021 | EDSA
Current and historical gross margin, operating margin and net profit margin for Edesa Biotech (EDSA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Edesa Biotech net profit margin as of June 30, 2021 is 0%.
|Edesa Biotech Annual Profit Margins
|Edesa Biotech Quarterly Profit Margins
||Medical - Biomedical and Genetics
Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage. Edesa Biotech Inc., formerly known as Stellar Biotechnologies Inc., is based in TORONTO.